Nanalysis Scientific Corp.
NSCIF
$0.1387
-$0.0013-0.93%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.90% | 24.66% | 57.44% | 64.79% | 51.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.90% | 24.66% | 57.44% | 64.79% | 51.54% |
| Cost of Revenue | -2.31% | 7.96% | 31.83% | 44.83% | 44.45% |
| Gross Profit | 34.39% | 99.62% | 215.40% | 193.81% | 82.59% |
| SG&A Expenses | -5.32% | -6.10% | -10.39% | -17.33% | -18.63% |
| Depreciation & Amortization | -7.73% | -6.87% | -1.78% | -7.81% | -8.90% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.49% | 2.49% | 14.98% | 16.20% | 13.53% |
| Operating Income | 53.16% | 73.33% | 74.56% | 63.75% | 51.21% |
| Income Before Tax | -0.39% | 17.23% | 20.85% | 63.17% | 23.01% |
| Income Tax Expenses | -100.76% | -96.20% | -6.12% | 157.87% | 164.13% |
| Earnings from Continuing Operations | 6.30% | 20.10% | 20.88% | 54.26% | 9.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -100.00% | -100.00% |
| Net Income | 6.30% | 18.89% | 18.02% | 51.60% | 2.23% |
| EBIT | 53.16% | 73.33% | 74.56% | 63.75% | 51.21% |
| EBITDA | 30.12% | 85.73% | 93.40% | 75.33% | 66.78% |
| EPS Basic | 14.36% | 27.40% | 26.73% | 55.53% | 9.48% |
| Normalized Basic EPS | 47.56% | 60.08% | 57.55% | 51.42% | 34.40% |
| EPS Diluted | 10.60% | 22.92% | 22.73% | 51.51% | 11.29% |
| Normalized Diluted EPS | 47.56% | 60.08% | 57.55% | 51.42% | 34.40% |
| Average Basic Shares Outstanding | 8.06% | 11.62% | 11.57% | 10.65% | 9.68% |
| Average Diluted Shares Outstanding | 8.06% | 11.62% | 11.57% | 10.65% | 9.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |